Novo Nordisk A/S Common Stock · Total Current Liabilities

Latest reportedkr 215.66B DKKperiod endingDec 31, 2025

NVO FY Current Liabilities · DKK (kr 1.60B → kr 215.66B)

Annual total current liabilities

High-resolution chart · PNG

NVO total current liabilities history

Annual fiscal periods · DKK. Dates are reporting period ends; fiscal years can differ from calendar years.

Novo Nordisk A/S Common Stock Total Current Liabilities — Annual fiscal periods (DKK)
Period ending	Total Current Liabilities (DKK)
Dec 31, 2025	215,661,000,000
Dec 31, 2024	217,528,000,000
Dec 31, 2023	169,655,000,000
Dec 31, 2022	120,940,000,000
Dec 31, 2021	99,516,000,000
Dec 31, 2020	70,273,000,000
Dec 31, 2019	58,983,000,000
Dec 31, 2018	54,164,000,000
Dec 31, 2017	47,056,000,000
Dec 31, 2016	47,436,000,000
Dec 31, 2015	40,873,000,000
Dec 31, 2014	33,689,000,000
Dec 31, 2013	24,225,000,000
Dec 31, 2012	21,638,000,000
Dec 31, 2011	20,779,000,000
Dec 31, 2010	18,476,000,000
Dec 31, 2009	13,415,000,000
Dec 31, 2008	12,987,857,600
Dec 31, 2007	10,657,576,000
Dec 31, 2006	10,159,778,800
Dec 31, 2005	10,565,470,480
Dec 31, 2004	7,331,714,160
Dec 31, 2003	6,645,874,800
Dec 31, 2002	5,959,414,980
Dec 31, 2001	5,989,825,170
Dec 31, 2000	6,416,960,000
Dec 31, 1999	6,564,992,880
Dec 31, 1998	5,485,636,926
Dec 31, 1997	5,314,656,924
Dec 31, 1996	3,673,564,727
Dec 31, 1995	3,937,036,800
Dec 31, 1994	4,578,917,700
Dec 31, 1993	3,691,044,000
Dec 31, 1992	3,423,530,500
Dec 31, 1991	3,856,193,350
Dec 31, 1990	4,167,961,600
Dec 31, 1989	3,646,679,250
Dec 31, 1988	2,727,603,200
Dec 31, 1987	2,117,924,100
Dec 31, 1986	2,196,141,750
Dec 31, 1985	1,602,763,200